Search our Database of Scientific Publications and Authors

I’m looking for a

    Details and Download Full Text PDF:
    Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report.

    BMC Nephrol 2017 Jul 18;18(1):243. Epub 2017 Jul 18.
    Baylor College of Medicine, Department of Pediatrics, Renal Section, Houston, TX, USA.
    Background: Hemolytic uremic syndrome (HUS) can occur as a primary process due to mutations in complement genes or secondary to another underlying disease. HUS sometimes occurs in the setting of glomerular diseases, and it has been described in association with Denys-Drash syndrome (DDS), which is characterized by the triad of abnormal genitourinary development; a pathognomonic glomerulopathy, diffuse mesangial sclerosis; and the development of Wilms tumor.

    Case Presentation: We report the case of a 46, XX female infant who presented with HUS and biopsy-proven thrombotic microangiopathy. Next generation sequencing of genes with known mutations causative of atypical HUS found that she was homozygous for the Complement Factor H H3 haplotype and heterozygous for a variant of unknown significance in the DGKE gene. Whole exome sequencing identified a de novo heterozygous WT1 c.1384C > T; p.R394W mutation, which is classically associated with Denys-Drash syndrome (DDS). At the time of bilateral nephrectomy five months after her initial biopsy, she had diffuse mesangial sclerosis, typical of Denys-Drash syndrome, without evidence of thrombotic microangiopathy.

    Conclusion: This unique case highlights HUS as a rare but important manifestation of WT1 mutation and provides new insight into the genetics underlying this association.
    PDF Download - Full Text Link
    ( Please be advised that this article is hosted on an external website not affiliated with PubFacts.com)
    Source Status
    http://dx.doi.org/10.1186/s12882-017-0643-1DOI ListingPossible
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516385PMCFound

    Similar Publications

    Novel WT1 mutation (C388Y) in a female child with Denys-Drash syndrome.
    Pediatr Nephrol 2001 Aug;16(8):627-30
    Division of Pediatric Nephrology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA.
    We report the identification of a novel Wilms tumor suppressor gene mutation in a 5-month-old girl who presented with unilateral Wilms tumor (WT) and renal diffuse mesangial sclerosis typical of Denys-Drash syndrome (DDS). The patient did not have ambiguous genitalia and the karyotype (by amniocentesis) was 46, XX. A de novo constitutional heterozygous mutation in WT1 gene exon 9 coding for the third zinc-finger (1163G-->A, C388Y) was identified. Read More
    Denys-Drash syndrome.
    Medicina (Kaunas) 2005 ;41(2):132-4
    Department of Human Genetics, Ulm University, Germany.
    Constitutional missense mutations in the WT1 gene are usually associated with Denys-Drash syndrome. This rare syndrome is characterized by a rapid progressive nephropathy, male pseudohermaphroditism, and an increased risk for Wilms tumor. We report on a patient with incomplete Denys-Drash syndrome, which was evident by the clinical data and proved by molecular genetics methods. Read More
    A familial WT1 mutation associated with incomplete Denys-Drash syndrome.
    Eur J Pediatr 2013 Oct 29;172(10):1357-62. Epub 2013 May 29.
    Department of Nephrology, Nanjing Children's Hospital, Nanjing Medical University, Nanjing, 210008, Jiangsu Province, China.
    Unlabelled: Denys-Drash syndrome (DDS) is a rare disorder characterized by nephropathy, male pseudohermaphroditism, and wilms tumor. Cases are thought to arise sporadically through a de novo mutation in the wilms tumor suppressor gene (WT1), which encodes a zinc finger protein that not only acts as a tumor suppressor but is essential for normal gonadogenesis, nephrogenesis, and development of the urogenital tract. In this report, we describe a family with the well-known missense mutation in exon 9 of the WT1 gene, 1180C>T (R394W), causing incomplete DDS and no symptoms in their father. Read More
    [A case of Denys-Drash syndrome with prophylactic bilateral nephrectomy].
    Nihon Jinzo Gakkai Shi 2003 ;45(1):42-6
    Division of Nephrology and Bone Metabolism, Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka.
    Denys-Drash syndrome is a rare disorder consisting of pseudohermaphrodism, Wilms' tumor and nephropathy. We describe here a boy with severe hypospadias and undescended testes, who presented with end-stage renal failure at the age of 1 year and 8 months when he was referred to our hospital. Emergency hemodialysis was performed because of oliguria, edema and severe hypertension, and then peritoneal dialysis was started. Read More